CEO Business Update
Filed with ASX · · 4 pages · English
Summary by 6ix AI
This filing is a CEO business update from ImpediMed Limited, detailing recent organizational changes and strategic initiatives to enhance sales and customer engagement. The company has established two new leadership roles aimed at driving SOZO device sales and improving customer retention. ImpediMed reports encouraging sales momentum and significant engagement at recent medical conferences, which are crucial for pipeline development. The update highlights ongoing efforts in cancer survivorship, weight management, and heart health, showcasing the company's commitment to expanding its market presence.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/ceo-business-update
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings CallEarlier from Impedimed
- Equity Raising Investor Presentation
- ImpediMed announces a successful $15.2 million Capital Raise
- Quarterly Activities Report and Appendix 4C - Mar-2026 Qtr
- ImpediMed Appoints Erik Anderson as Chief Executive Officer
- Appointment of CEO/Managing Director
Later from Impedimed
- Oversubscribed Share Purchase Plan Successfully Completed
- Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr
- Quarterly Activities Report and Appendix 4C - Sep-2026 Qtr
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed